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actually helped us-[it] took a lot of stuff
that had settled on the bottom, came up high
enough, and left fast enough so it maygive us
some help," he says. "But then in a fewyears,
it'll fill back in. A hurricane can't hurt you;
long-term, [hurricanes] have been around
forever. Hopefully, it took more stuffoffthe
bottom than it put on the bottom. NextJune
orJulywill tell.
NAS Says EMFs No Hazard
A new report by a committee of the
National Academy ofSciences paints a rosy
picture ofhousehold electromagnetic fields
(EMFs), concluding that "no conclusive and
consistent evidence" suggests a human-
health hazard, and that, in fact, strong, low-
frequency pulsed magnetic fields may actu-
allyhelp heal broken bones.
But the 31 October 1996 report also
calls for additional research to answer linger-
ing questions about EMFs, such as why
intense magnetic fields seem to speed the
development of breast cancer in laboratory
animals subjected to chemical carcinogens.
Epidemiological studies since 1979 have
shown a "weak but statistically significant"
(1.5-fold) increase in leukemia among chil-
dren living in homes exposed to high-level
EMFs, the NAS report notes. Most ofthese
studies can be called into question, however,
because they rely on rough estimates ofinte-
rior exposure levels based on outdoor wiring
configurations orwire codes, said NAS com-
mittee chair Charles F. Stevens, a professor
and investigator with the Howard Hughes
Medical Institute at Salk Institute in La
Jolla, California. Epidemiology studies have
also failed to rule out other potential risk
factors for childhood leukemia, such as the
proximity ofchildren's homes to high-traffic
areas, Stevens added.
"There is not one shred ofevidence that
it's the [EM] fields that are causing this asso-
ciation with childhood leukemia," Stevens
said. "In all the animal studies, there's not
one casewhere we know that the effects that
have been seen are detrimental versus bene-
ficial. There's no evidence that any effects
takeplace in humans."
At the Midwest Research Institute in
Kansas City, Missouri, Senior Advisor
Charles Graham said people exposed to
magnetic fields at levels as low as 12 milli-
gauss (a range common inside homes) expe-
rience heart-rate changes. "We do have
reproducible effects," Graham said of his
research, but he added that such effects are
"not [health] risks, necessarily.... We don't
knowifthey're risks ornot."
In fact, the NAS report says, EMF stud-
ies show detrimental health effects only
when exposure levels are 1,000-100,000
times stronger than those found in a typical
residential setting. Overall, the report says,
no evidence points to household EMFs as a
cause for cancer, adverse neurobehavioral
effects (such as schizophrenia or learning
disabilities), or reproductive and develop-
ment disorders. Though preliminary studies
suggested that EMFs might increase cancer
risks by inhibiting the production of the
hormone melatonin, Stevens said, subse-
quent research failed to support this theory.
Moreover, Graham said, EMFs seem to sup-
press melatonin production only in animals,
not in humans.
A number of recent studies, including
work by NAS committee member Maria A.
Stuchly, have shown "a slightly earlier devel-
opment oftumors" among rodents exposed
to chemical carcinogens aswell as EMFs, the
report says. But such co-promotional effects
"have not been replicated," said Stuchly, a
professor at the University ofVictoria in
British Columbia. Nevertheless, the report
says, researchers should reevaluate copromo-
tional studies-especially the work of
German researchers (W. Loscher and col-
leagues), who reporteda 50% increase in the
growth rate ofmammarytumors among rats
exposed to 50-Hz magnetic fields after
receiving oral doses of the carcinogen
DMBA.
Studies ofpossible copromotional effects
i-I-
Taking Inventory of Toxics
Byproviding direct access to information that otherwisewould be difficult to obtain, the
Internet has enabled many people to take an active role in investigating and solving their
problems. With the creation ofthe Toxic Release Inventory System (TRIS), the EPA has
expanded this ability by making it much easier for Americans to track and eliminate
pollution. The TRIS page on the World Wide Web, located at
hntp://www.epa.gov/enviro/htmlI/tris/tris overview.html, provides information to anyone
with Internet access on the more than 300 toxic
substances that the EPA tracks. Industries that
release any of these chemicals must submit a (RJ) Toxic Release Inventory to the EPA each year.
The data from these forms are compiled into a
searchable database that can be accessed by selecting the TRIS Queries link on the TRIS
homepage.
TheTRIS search form allows users agreat deal offlexibility in deciding howtheir search
will be conducted. With the top halfofthe form, users can specify what criteria they want
matches toftulfill-whether theywanttheTRIS to displayfacilities carryingacertain nameor
identification, facilities within a certain geographical region, facilities ofa certain industrial
classification, or facilities that emit a certain chemical. With the bottom halfof the form,
users candictate howtheresultswilllookandwhatinformationTRISwill display. Forexam-
ple, ifauserwanted to knowifindustries were releasing mercury intowaters nearacity, they
could simplyspecify the city, county, or zip code in the geography andspecify "mercury" in
the Chemical Search Option field. After picking option eight to display the search results by
'Amounts and Names ofChemicals Released to Surface Waters," users will receive a nicely
formatted reportofall the industries releasing mercuryinto thewaters in that area. Thesame
search couldbe done using"sulfur dioxide" in theChemical Search Option field anddisplay-
ing results by Amounts and Names ofChemicals Released to Air for information on acid
rain. For other searches, users may want to display results with the Facility Business and
Contact Information option. For further information on how to use the TRIS, a User's
Guide link is provided on the query page. Information on the timeliness and accuracy of
TRIS datacan be obtainedthrough links on thehomepage.
When searching TRIS, it is sometimes hard to specify chemicals since many have more
than one name. A helpful way to avoid this problem is to search for a chemical using the
number assigned to it bythe ChemicalAbstracts Service (CAS). To do this, users mustselect
the appropriate option from the pull-down menu over the Chemical Search Option field.
CAS numbers can be obtained from a helpful list compiled by Genium Publishing at
hup-://www.genfo.com/cgi-binldli-search.cgi?md=y.
The Environmental Systems Research Institute provides a more user-friendly way to
search for Toxic Release Inventory information at http://maps.esri.com/toxic.htm. This
search fbrm does notallowforas muchflexibility as the EPAform, and thedatahere are not as
current, buttheprogramreturns theresultsaspointsonastreetmapoftheareainquestion. The
ability ofaverage citizens to see how dose polluters are to-where they live, work, and play is a
novelphenomenaandperhapsthefirststeptosolvingsomeoftheproblemsoftoxicpollution.
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are already underway at the NIEHS, as part
ofthe EMF RAPID (Electric and Magnetic
Fields Research and Public Information
Dissemination) Program. In fact, Program
Director Gary Boorman reports, NIEHS
researchers recently attempted to replicate
the German study ofbreast cancer develop-
ment in rodents. Boorman expects to see
completed data from that study within 8
months. A second, two-year study involving
100 animals subjected to slightly lower
chemical doses in conjunction with longer-
term exposure to EMFs should also be com-
pleted soon, he says. "The NAS report was a
good report," he says. "But it did not
include many ofthe RAPIDstudies, because
they didn't look at much data after 1994.
We hope to prepare a report for Congress in
1998 that will allow us to examine the
wealth ofdataproduced since 1994."
The congressionally mandated NAS
report-prepared by a 16-member commit-
tee including David A. Savitz, a professor at
the University ofNorth Carolina at Chapel
Hill whose carefully controlled epidemiolog-
ical studies have consistently suggested an
association between EMFs and cancer-may
deal another blow to a draft report of the
National Council on Radiation Protection
and Measurements (NCRP), which calls for
a 2-milligauss limit on EMFs near day-care
centers, schools, playgrounds, and newly
built homes within the next 10 years.
Portions of the draft appeared in the
July/August 1995 issue ofMicrowave News,
though it still has not cleared the NCRP's
exhaustive peer-review process. "It seems to
have entered an NCRP black hole,"
observed MNEditor Louis Slesin, who faults
the NAS report foremphasizing the need for
"conclusive" evidence of an EMF-related
health hazard. "That's a very harsh burden,"
he said, adding that researchers have not
conclusively ruled out EMFs as the cause of
reported increases in childhood leukemia.
Until such questions are resolved, says
Jack Sahl, a senior research scientist and
manager of the Health Research and
Evaluation Division at Edison International
in Rosemead, California, utilities and policy-
makers would be wise to adopt "precaution-
based" strategies for minimizing anypossible
health risks. [See EHP 104:908-911 (1996).]
For example, Sahl said in an interview,
Edison International has prepared a manual
offering common-sense guidelines for mini-
mizing EMF exposure risks when designing
new buildings. Similarly, since 1989, the
California Department of Education has
avoided building new schools in dose prox-
imityto high-voltage powerlines.
No federal legislation is pending to limit
EMF exposure, Sahi says, and policymakers
who once championed exposure limits,
including Representative George Miller (D-
California.), now seem to be backing away
from the issue. The $600,000 NAS report
was requested by Representative Joseph M.
McDade (R-Pennsylvania) in response to
constituent concerns in Scranton,
Pennsylvania, where a utility company
wanted to install high-voltage power lines
near homes. (McDade's press secretary, Jake
O'Donnell, says the power company subse-
quently decided to relocate its power lines.)
Though he hasn't identified a specific EMF
research agenda, O'Donnell says, McDade
will probably heed recommendations set
forth by the NAS committee, which recom-
mended more stringent epidemiological
studies incorporating accurate measure-
ments of magnetic fields inside homes and
strategies for answering questions about
childhood leukemia. The NAS report also
recommended a host of biological studies.
For example, the committee said,
researchers should identify the mechanism
by which EMFs seem to promote bone-
healing in animals.
New Protein Kinase Inhibitors
Swiss researchers are exploring a vast new sea
ofcompounds that attack cancer cells at the
genetic level. "Phenylamino-pyrimidines are a
new class of potent and selective protein
kinase inhibitors," saidJeurgZimmermann, a
project leader with the pharmaceutical divi-
sion ofCIBA-Geigy in Basel. The key to use
of the phenylamino-pyrimidines (PAPs),
Zimmermann said, is their selectivity. "A lot
ofcompounds can attack protein kinases," he
said, but if the compound doesn't select for
specific enzymes, the subject cannot survive.
PAPs tend to select certain protein kinases,
such as protein kinase C (PKC), a calcium-
dependent enzyme that is overexpressed in
tumor cells. Throttling PKC with PAPs may
result in the tumor being unable to grow or
reproduce, and can possibly make it regress.
Zimmermann said another kinase that is
commonly overexpressed in cases of
gliomablastoma, a usually fatal brain cancer,
is platelet-derived growth factor receptor
(PDGF-R). In some laboratory mice that
have been implanted with gliomablastoma
tumors, the introduction ofcertain PAPs has
brought the growth ofthe tumor to a stand-
still, has prevented other cells from develop-
ing the tumor, or has actually caused the
tumor to regress, said Zimmermann.
Zimmermann and his colleagues chose to
study the means of attacking the protein
kinases, ofwhich there are more than 200,
because ofthe molecules' roles in signal trans-
duction and cell proliferation, both ofwhich
are responsible for a cascade ofevents leading
to cancer growth and metastasis in the body.
In a presentation at the American
Chemical Society meeting in Orlando,
Florida, Zimmermann demonstrated how
rational drug design procedures, using pyrim-
idines-one of the main building blocks of
DNA and RNA-have resulted in the syn-
thesis of more than 500 compounds. Using
pyrimidines as a base, scientists add various
analogs to the pyrimidine until they discover
a compound that looks as if it will attack a
specific area ofa cancer cell. Typically, scien-
tists will develop numerous chemical vari-
eties. Although "only about 10% ofthe com-
pounds have shown any anticancer activity,"
Zimmermann said, several ofthe compounds
that did limit tumor growth are now being
studied further before they are tested in
humans. "We have to test toxicity and phar-
macokinetics to see if the drug gets into the
bloodstream and can be ofuse therapeutical-
ly," hesaid.
"Rational drug design," said Theodore
Friedmann, director ofthe gene therapy pro-
gram at the University of California at San
Diego, "is a common device utilized to man-
ufacture chemicals that are likely to have an
effect on treatment of some disease. Most
drugs are developed using this procedure in
laboratories, although other drugs are still
commonly found by investigating organic
compounds such as tropical earths."
By and large, Friedmann said, the use of
rational drug design will result in an incre-
mental increase in fighting a disease such as
cancer. "We have hundreds of compounds
that show some ability to fight cancer cells,"
he said, "which really testifies to the fact that
we have very few drugs that really work well
in destroying cancer cells. We use one for a
while and when that stops working we go to
another." But, he said, "occasionally some-
thing comes along that breaks the curve."
Zimmermann said he is encouraged that
some of the PAPs being scrutinized by his
team have shown a wide range ofsuccess on
various tumors, including brain, breast, and
bladder cell lines. More exciting, he said, is
that some ofthe compounds are so selective
they will inhibit PDGF-R, necessary for the
growth ofbrain cancer cells, but will have no
effect on other tumor lines, indicating an
ability to be carefully fine-tuned into specific
tumorkillers.
Fungi Fighting Back
Just as many bacteria and viruses have
become resistant to pharmaceuticals, fungi
have been developing drug resistance over the
past five years. At the same time, new fungal
pathogens are emerging and previously iden-
tified rare fungal pathogens are re-emerging,
resulting in rising morbidity, mortality, and
costs, according to a report byDennis Dixon,
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